A new report from the Childhood Cancer Survivor Study (CCSS) showed that childhood cancer survivors were almost five times more likely to have post-traumatic stress disorder (PTSD) than their siblings who did not have cancer as children.

A second report from the CCSS found that not enough survivors of childhood cancer receive screening for colon, skin, and breast cancers.

Adding a cancer treatment vaccine to the standard treatment improved survival for children with neuroblastoma.

Researchers from the Children’s Oncology Group (COG) looked at whether giving chemotherapy to patients with Ewing’s sarcoma every 2 weeks instead of every 3 weeks was more effective.

In an analysis of data from the Childhood Cancer Survivorship Study (CCSS), researchers compared the development of heart disease in 14,358 childhood cancer survivors with 3,899 of their siblings.

Results of a new study show that the majority of survivors of childhood cancer do not receive specialized long-term medical care, even though they are known to be at high risk for long-term health problems.

Lower doses of chemotherapy yield survival rates higher than 90% for infants and children with stage III or IV neuroblastoma, a new study finds. Neuroblastoma is a cancer that forms in the nerve tissues in the neck, chest, abdomen, pelvis, or adrenal gland in infants and young children. Although survival rates are generally high with the current standard treatment, the treatment can have long-term side effects, such as heart and kidney damage and hearing loss.